This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v1.0.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Active as of 2024-12-06 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="nhi-tx-ast"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem nhi-tx-ast</b></p><a name="nhi-tx-ast"> </a><a name="hcnhi-tx-ast"> </a><a name="nhi-tx-ast-en-US"> </a><p>This case-sensitive code system <code>https://twcore.mohw.gov.tw/ig/pas/CodeSystem/nhi-tx-ast</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">ICLL<a name="nhi-tx-ast-ICLL"> </a></td><td>iwCLL (International Workshop on CLL)</td></tr><tr><td style="white-space:nowrap">IREC<a name="nhi-tx-ast-IREC"> </a></td><td>i-RECIST criteria</td></tr><tr><td style="white-space:nowrap">MREC<a name="nhi-tx-ast-MREC"> </a></td><td>mRECIST criteria</td></tr><tr><td style="white-space:nowrap">REC1<a name="nhi-tx-ast-REC1"> </a></td><td>RECIST 1.1 criteria</td></tr><tr><td style="white-space:nowrap">IWGC<a name="nhi-tx-ast-IWGC"> </a></td><td>International Working Group(IWG) Consensus Criteria</td></tr></table></div>
</text>
<url value="https://twcore.mohw.gov.tw/ig/pas/CodeSystem/nhi-tx-ast"/>
<version value="1.0.1"/>
<name value="NHITreatmentAst"/>
<title value="NHI-健保事前審查-治療後疾病狀態評估項目"/>
<status value="active"/>
<experimental value="false"/>
<date value="2024-12-06"/>
<publisher value="衛生福利部中央健康保險署"/>
<contact>
<name value="衛生福利部中央健康保險署"/>
<telecom>
<system value="url"/>
<value value="https://www.nhi.gov.tw"/>
</telecom>
</contact>
<description
value="臺灣衛生福利部中央健康保險署「治療後疾病狀態評估項目」代碼,代碼出版日期:2024-12-06;資料所屬單位:臺灣衛生福利部中央健康保險署。"/>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="5"/>
<concept>
<code value="ICLL"/>
<display value="iwCLL (International Workshop on CLL)"/>
</concept>
<concept>
<code value="IREC"/>
<display value="i-RECIST criteria"/>
</concept>
<concept>
<code value="MREC"/>
<display value="mRECIST criteria"/>
</concept>
<concept>
<code value="REC1"/>
<display value="RECIST 1.1 criteria"/>
</concept>
<concept>
<code value="IWGC"/>
<display value="International Working Group(IWG) Consensus Criteria"/>
</concept>
</CodeSystem>